MILAN (AIMnews.it) - The total value exchanged during the week is € 28.9 million; 34 positive titles with an average of + 2.36%. The FTSE AIM Italia scored -0.22%. The FTSE Italia PIR PMI All posted a performance of -1.66%. The 5 best performances of the week: Gambero Rosso: 11.62% (CMG Euro 252.486) Net Insurance: 6.71% (CMG Euro 46.520) Vetrya: 6.33% (CMG Euro 595.138) Notorious Pictures: 4.72% ( CMG Euro 19.044) Poligrafici Printing: 4.26% (CMG Euro 26.896) At sector level * the best performance was recorded by the Chemical sector (+ 1.5%), followed by the Healthcare sector (+ 0.8%) and the industry sector (+ 0.6%). Chemical Sector Performance: 1.5% (CMG Euro 856.780) Healthcare: 0.8% (CMG Euro 65.110) Industry: 0.6% (CMG Euro 39.751) Technology: 0.2% (CMG Euro 94.561) Food: 0, 1% (CMG Euro 135.828) Services: -0.3% (CMG Euro 26.327) Finance: -0.4% (CMG Euro 76.279) Average: -0.9% (CMG Euro 50.149) Fashion and Luxury: -1, 0% (CMG Euro 14.768) Renewable Energy and Energy: -2.3% (CMG Euro 14.496) Telecommunications: -5.9% (CMG Euro 20.718) * Sectoral classification by the IR TOP Observer (www.pmicapital.it ) The main News of the week Zephyro is awarded 530 million Euro Consip MIES2, Zephyro, target of the SPAC GreenItaly1, has obtained the final award of the first three lots of the Consip 'Mies2' tender for the supply of energy services for a total value around 530 million euros. "With the final and executive award of the 3 MIES lots for a total amount of 530 million euros for the next 7 years, our group achieves a result of excellence at the end of a long and demanding process - said President Domenico Catanese- This result attests our leadership in the field of energy efficiency in the health sector as well as the high technical skills of the company. We have achieved the highest level of quality and economic evaluation, confirming the company quality that has always distinguished us. We are starting a growth path that will allow us to achieve ambitious goals. The awarding of MIES represents an event of great importance for our company. "The ESCO is also awaiting the results of the procedure for awarding the 'ordinary lot 1' for an overall ceiling turnover equal to approximately 140 million euros. Zephyro closed 2017 with revenues of € 69.4 million, 15.9 million of ebitda (+ 49.4%) and € 1.7 million of net profit, with a net financial position of € 4.6 million. The Board of Directors will propose a dividend of € 0.10 per share to the Shareholders' Meeting called on April 24. Fope, revenues 28 million (+ 21%), ebitda 3.9 million (+ 72%), ebitda margin 13.9% Fope closed 2017 with € 28.03 million in revenues (+ 21.4% on 2016), 3.9 million ebitda (+ 72.1%), with a margin of 13.9% (9.8%) % in 2016) and 2.33 million in net profit: growth both in Italy and abroad, where it accounts for 82% of turnover, mainly thanks to the performance recorded on the European markets, + 24% (with Germany and United Kingdom at the top) and American at + 22%. Own assets amounted to € 11.92 million, with a net financial position of € 1.17 million. "We are pleased to close the 2017 financial statement by registering significant growth in all indicators and strong capital strength - explains AD Diego Nardin - Sales growth on the main foreign markets on which we are focusing investments, demonstrating that the actions undertaken are going in the right direction". The Board of Directors will propose to the Shareholders' Meeting - called for April 20 - a dividend of €0.125 with an ex-dividend date of 30 April. "The positive performance of the first months of the current year allows us to look at a 2018 of further creation and of value for our shareholders, pointing out in these days the closing of Fope Jewelery Limited, a company incorporated under English law, support of the same market, which will ensure the direct presence of the brand and greater efficiency of the interventions" concludes Nardin Finlogic, in 2017 revenues + 19%, net profit + 6% Finlogic in 2017 increased revenues by 19% to 21.4 million and EBITDA of 9% to 3.24 million, the net profit grew 6% to 1.67 million euros. The Board of Directors will thus propose a dividend of 0.1481 euros per share, with a payout of 62% and a yield of 2.9 per cent. "We conclude with satisfaction - explained AD Dino Natale - a year in which the Finlogic Group recorded a significant growth of all the indicators, with a better trend compared to the reference market and in line with the objectives to confirm the growth strategy announced in the IPO, performance is driven by technological products, which represent + 49% in terms of revenues. The outlook for 2018 is positive and Finlogic will pursue the goal of consolidating leadership in the automatic identification sector by leveraging both the collaboration with Hydra and the competitive advantage in commercial terms made to the Group's product portfolio through the acquisitions of Tecmark and Multitec. The two companies, whose purchase was finalised on January 24th 2018 and whose accounting effects are not reflected in the 2017 consolidated results, recorded in 2017 a € 0.6m ebitda which brings the aggregate ebitda of the group to approximately Euro 4,0 million. The 2017 profit of Tecmark equal to Euro 380.000 attributable to Finlogic will contribute to increasing the Group's equity items. Also important will be the commitment to the development of the foreign market thanks to the collaboration with international partners essential for our internationalisation strategy and increase of the market share abroad. "Kolinpharma, in 2017 + 62% revenues and + 130% ebitda. In 2017 Kolinpharma achieved 4.1 million in revenues, 62% more than the 2.5 million of the previous year. EBITDA rose from 0.26 to 0.6 million, while the net loss decreased from 0.37 to 0.07 million euros. "2017 was a year of strong growth for the company in terms of revenues and margins, confirming a winning company strategy, centered on significant investments in innovation and development of a widely diversified offer - explained Rita Paola Petrelli, chairman of innovative SMEs operating in the field of nutracetics - Also the strengthening of the commercial network is particularly strategic in order to raise awareness of the efficacy of nutraceutical products and on the peculiarities of our brands. In 2017 we started a path of strong corporate structure and through the listing on the AIM Italia market on March 9 in 2018 we aim to accelerate scientific research projects for the development of products with new pharmaceutical forms". At the end of 2017, equity was 1.2 million, while the net financial position was negative by 2.5 million "due to greater investments made mainly for research and development activities and for the launch and consolidation of the sales network". In fact, during the 2018 financial year, the company intends to focus on the development of products for therapeutic classes with high growth rates, innovative formulations and, from a commercial point of view, to widen the Medical-Scientific Informatics network to achieve optimal coverage of the territory and the specialist medical target of interest and obtain a significant market position". Kolinpharma, a clinically effective Xinepa integrator. A clinical study conducted at the Umberto I Hospital in Rome, which focused on the effects of Kolinpharma's Xinepa supplement, demonstrated the efficacy of the nutraceutical product for the treatment of peripheral neuropathies. The results of this study will be published in the journal 'The Journal of Physical Therapy Science'. Bomi Italia, increase production value and profits. In 2017 Bomi Italia increased the value of production by 17%, which amounted to 117.8 million euros; EBITDA rose by 9.4% to 11 million (+ 4% compared to the business plan) and group net profit amounted to 2 million euros, 58% more than expected. "The growth trend of the Bomi Group is confirmed, which in 2017 has achieved significant synergies and rationalised the group structure in support of margins, obtaining significant results above the data estimated in the plan", explains the biomedical logistics company. Net financial debt increased to 25.5 million, "mainly due to the acquisition of the minority interest in the Brazilian subsidiary in November 2017", concludes Bomi. Zephyro closes 2017 with ebitda growing by 49%. Dividend of 0.10 euros Zephyro closed 2017 with revenues of 69.4 million euros, substantially in line with the 70.1 million achieved in 2016. Ebitda grew by 49.4% to 15.9 million, profit was 1.7 million, compared to a loss of 0.3 million in the previous year. The net financial position is positive with 4.6 million. The BoD will propose to the Shareholders' Meeting, called for April 24th, a dividend of € 0.10 per share with ex-dividend date May 28 and the cancellation of treasury shares (698,504) and those redeemable (886,163). The share capital will thus remain unchanged at 1.2 million euros, while the total number of outstanding shares will decrease to 9.9 million. For Biodue 4.1 million net profit and 0.06 euros of Biodue dividend in 2017 increased revenues by 5.3% to 36.3 million euros. The profit almost doubled to 4.1 million euros. Total assets stood at 20.5 million, net financial debt is 6.3 million. The BoD will propose a dividend of 0.06 euros with a detachment date on June 4th. "The operations carried out in the last two years in 2017, have produced the first results witnessing the birth of the BioDue group, the consolidation of latent surplus values, a substantial increase in assets and, in the near future, constitute the tangible prerequisites of a growth process and the creation of value for shareholders, which will also accelerate due to landing in the STAR segment of the Italian Stock Exchange", commented the president Vanni Benedetti. Clabo, revenue projections from the US rise to 18.5 million dollars. Howard McCray, a US company recently acquired by Clabo, has received confirmation of orders for 1.5 million dollars from the Dollar General chain for the second quarter of 2018. The total annual sales thus rose to $ 2.3 million and projections of revenues in the US to 16 million dollars, to which must be added the 2.5 million coming from the merger with Clabo USA. "The acquisition of HMC is proving better than expected - said Clabo president Pierluigi Bocchini - The potential of the US market is enormous and for Clabo the partnership with HMC is confirming its absolute value in terms of the prospective development of the new industrial plan that we will present on April 5th in Milan". Fusion between Gambero Rosso and Class Editori. Fusion between Gambero Rosso and Class Editori: the operation, explains 'Class' "is aimed at creating the first Italian media company producing not only content, but also services for companies and consumers, in Italy and abroad, in the sectors of excellence through 'Made in Italy'". In detail, Pim spa, a majority shareholder of Gambero Rosso, headed by Paolo Cuccia, will confer, in a reserved capital increase, its 67.48% stake, for a value of 15 million euros (Gambero Rosso has been valued at 22.31 million) in 'Class' and will have 27.96% of the publishing group in via Burigozzo (valued at 38.7 million), which will subsequently launch an option on the float of Gambero Rosso. Cuccia, who will be co-opted in the Class Board of Directors and appointed managing director with powers to manage company activities, will also indicate two other directors. THE COMPANIES AIM 4AIM SICAF: 0.00% Living In: -3.70% Agatos: -0.69% Alfio Bardolla Training Group: 2.52% Alkemy: -0.32% Alp.I: 2.13% Ambromobiliare: -1.88% Assiteca: -0.40% axélero: -7.55% BioDue: -0.20% Bio-on: 1.46% Blue Financial Communication: -10.00% Bomi Italia: 1, 90% Caleido Group: 0.00% Capital For Progress 2: -0.50% Casta Diva Group: -0.34% CdR Advance Capital: 2.42% Clabo: 1.11% Cover 50: 0.62% Growth : 0.00% Milan Cults: 2.87% DBA Group: 0.00% DHH: 0.00% Digital Magics: -2.51% Digital360: 0.82% DigiTouch: -3.36% Ecosuntek: -3 , 85% Elettra Investimenti: 2.71% Energica Motor Company: -3.67% Energy Lab: -3.82% Enertronica: 1.37% EPS Equita PEP: -1.00% Equita Group: -0.62% Expert System: 0.77% Finlogic: 2.79% Fintel Energia Group: -4.76% First Capital: 0.00% FOPE: -0.72% Frendy Energy: -2.92% Gambero Rosso: 11.62 % Gel: -1.75% Giorgio Fedon & Sons: -1.68% Glenalta: -1.94% GO Internet: -5.88% GPI: 0.94% Green Power Group: -3.20% Health Italy : 1.98% H-FARM: -0.72% IdeaMI: 0.21% Illa: 0.46% Imvest: -2.33% Industrial Stars of Italy 3: -0.20% Brescian initiatives: -4.35% Innova Italy 1: -0.51% Innovatec: -3, 90% Italia Independent Group: -2.40% Italian Wine Brands: 3.04% Ki Group: -1.65% Kolinpharma: -1.43% Leone Film Group: -2.04% Life Care Capital: -3, 20% Lucisano Media Group: -1.35% MailUp: -2.11% Masi Agricola: -2.09% Modelleria Brambilla: 0.00% Mondo TV France: -3.24% Mondo TV Suisse: -1.82 % Neodecortech: 2.57% Net Insurance: 6.71% Neurosoft: 0.00% Notorious Pictures: 4.72% Vrsar: 1.00% Pharmanutra: 1.57% Piteco: 2.05% PLT Energy: 0, 71% Poligrafici Printing: 4.26% Portal Sardinia: 0.00% Prisms: -7.05% Sea Rosetti: 0.00% SMRE: 2.00% Safe Bag: -3.32% SCM SIM: 1.01 % Sit: 3.64% B & T Group SITI: -0.46% Softec: 0.00% Spactiv: -1.00% Spaxs: -1.22% Sprintitaly: 0.00% Telesia: -1.93% TPS : -2.37% Triboo: -4.13% Vei 1: -0.10% Vetrya: 6.33% Visibilia Editore: 0.65% WIIT: 0.21% WM Capital: 1.23% Zephyro: - 4.66%